# Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies

Source: https://onco.cc/trials/nct07599995/  
OnCo record `nct07599995` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of envafolimab, gemcitabine and cisplatin in gallbladder cancer and other biliary tract cancers, run by Sir Run Run Shaw Hospital, not yet recruiting.

## Summary

Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies is a phase 2 interventional study registered as NCT07599995 by Sir Run Run Shaw Hospital, with a registry enrolment figure of 34 participants, started 2026-05-30 and due to reach its primary completion in 2028-03-30. Interventions recorded: Neoadjuvant therapy followed by surgery. Conditions listed: Biliary Tract Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: GENE
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07599995
- Phase: 2
- Setting: The Efficacy and Safety of Gemcitabine-Cisplatin Plus Envafolimab as Neoadjuvant Therapy in Resectable Biliary Tract Malignancies at High Risk of Recurrence
- Sponsor: Sir Run Run Shaw Hospital
- Enrolled: 34

## Sources

- ClinicalTrials.gov NCT07599995: https://clinicaltrials.gov/study/NCT07599995

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Cisplatin](https://onco.cc/drugs/cisplatin/), [Envafolimab](https://onco.cc/drugs/envafolimab/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07599995.json